A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants

NCT02260700 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-54861911 (Treatment A)
DRUG: JNJ-54861911 (Treatment B)
DRUG: JNJ-54861911 (Treatment C)

Sponsor

Janssen Research & Development, LLC